Physician profile
Roy Devonne Flood
NPI 1336124338
$86,884.75
in general payments reported to CMS, 2019-2025
57 companies · $4,532 in 2025
The $4,532 reported for 2025 was more than what 91% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43K · 2020: $4,994 · 2021: $12K · 2022: $5,020 · 2023: $12K · 2024: $6,387 · 2025: $4,532.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $6,600 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,500 · Travel and Lodging: $2,185 · Education: $126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,242.20 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $6,600.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,500.00 |
| Travel and Lodging | $2,184.64 |
| Education | $126.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $24,485.07 | 2019-2025 | Jardiance |
| Lilly USA, LLC | $18,986.10 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $12,434.94 | 2019-2025 | Farxiga, Brilinta, Wainua |
| Shockwave Medical, INC | $9,261.37 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $3,995.26 | 2019-2025 | Watchman Access System, Avvigo Guidance System, Watchman Flx |
| Medtronic, INC. | $2,291.52 | 2022-2025 | Onyx Frontier, Symplicity G3, Ffrangio |
| Actelion Pharmaceuticals US, INC. | $1,635.99 | 2019-2025 | Opsumit, Uptravi, Opsynvi |
| Abiomed | $1,418.62 | 2019-2025 | Impella |
| Janssen Pharmaceuticals, INC | $1,324.79 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,290.42 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $1,030.11 | 2019-2025 | |
| Amgen INC. | $871.71 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $792.77 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $643.52 | 2019-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $639.02 | 2021-2025 | Verquvo, Winrevair, Belsomra |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $531.44 | 2023-2025 | Barostim Neo System |
| Celonova Biosciences, INC. | $504.02 | 2019-2020 | |
| Medicure Pharma INC. | $497.58 | 2020 | |
| Esperion Therapeutics, INC. | $450.67 | 2020-2024 | Nexletol |
| United Therapeutics Corporation | $444.46 | 2023-2025 | Tyvaso, Tyvaso |
| Philips North America LLC | $286.07 | 2020-2025 | Ambulatory Monitoring & Diagnostics Undivided, Ecc Solutions |
| Lexicon Pharmaceuticals, INC. | $241.07 | 2023-2024 | Inpefa |
| Bayer Healthcare Pharmaceuticals INC. | $211.90 | 2021-2025 | |
| Angiodynamics, INC. | $197.86 | 2024-2025 | Auryon Laser System 100-120 Vac |
| Inari Medical, INC. | $176.71 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Alnylam Pharmaceuticals INC. | $170.35 | 2025 | Amvuttra, Onpattro |
| Medtronic Vascular, INC. | $166.55 | 2019-2020 | |
| Edwards Lifesciences Corporation | $159.69 | 2022-2025 | Sapien 3 Ultra Resilia |
| Penumbra, INC. | $155.24 | 2025 | Indigo System |
| Recor Medical INC | $145.89 | 2024 | Paradise Renal Denervation System |
| Novo Nordisk INC | $135.66 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Baxter Healthcare | $133.28 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor |
| Ge Healthcare | $119.39 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $106.22 | 2021-2023 | Arcalyst |
| Kiniksa Pharmaceuticals International, Plc | $94.61 | 2024 | Arcalyst |
| Lundbeck LLC | $87.07 | 2019 | |
| Siemens Medical Solutions USA, INC. | $76.79 | 2019 | |
| Cardiva Medical, INC. | $75.13 | 2024-2025 | Optowire |
| Scpharmaceuticals INC. | $65.01 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $55.66 | 2019 | |
| Abbott Laboratories | $53.81 | 2021-2023 | Aveir |
| Vital Connect, INC | $50.16 | 2023 | Vitalpatch Rtm |
| Johnson & Johnson Health Care Systems INC. | $47.90 | 2023 | Opsumit, Uptravi |
| Kowa Pharmaceuticals America, INC. | $44.68 | 2020-2021 | |
| Bardy Diagnostics, INC. | $43.43 | 2019-2022 | |
| Cardiovascular Systems INC. | $34.00 | 2021-2023 | Diamondback Coronary |
| Sanofi-Aventis U.S. LLC | $32.61 | 2019 | |
| Chiesi USA, INC. | $29.54 | 2019-2021 | |
| Idorsia Pharmaceuticals US INC | $21.50 | 2023 | Quviviq |
| Medicomp INC | $20.50 | 2022 | |
| Acist Medical Systems, INC. | $19.21 | 2019 | |
| Dexcom, INC. | $18.77 | 2025 | Dexcom G6 Transmitter |
| Cleerly, INC. | $18.21 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Itamar Medical INC | $17.43 | 2023 | Watchpatone |
| Amarin Pharma, INC. | $16.99 | 2021 | |
| Cardinal Health 200 LLC | $13.56 | 2019 | |
| Allergan, INC. | $12.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Flood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.